Micropulse Transscleral Cyclophotocoagulation for the Management of Diverse Glaucoma Types: A Multicenter Short-Term Real-World Study

MP-TSCPC safely provides sustained IOP control and medication reduction across diverse glaucoma types, supporting its role as a versatile alternative for both refractory and functional eyes with glaucoma. The real-world, multicenter nature of this study enhances its external validity, although its retrospective design and 12-month follow-up limit long-term generalizability.